Raised ZHX1 and reduced ZHX2 levels, as described recently [22], were also observed in silico in primary HL patient samples (S3 Fig), consolidating the cell line data and the clinical relevance of these genes. Here, ZHX1 is linked to Hodgkins lymphoma.